PASSAGE BIO INC. - CO
0.6210
25-11月-24 16:45:01
15 分の遅延
株式
+0.1160
+22.97%
本日の幅
0.4709 - 0.6900
ISIN
N/A
ソース
NASDAQ
-
Passage Bio to Participate in Upcoming April Investor Conferences
25 3 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
22 3 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
08 3 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
03 3 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming March Investor Conferences
02 3 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
24 2 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
19 2 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
28 1 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Pricing of Public Offering
21 1 2021 19:48:12 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Launch of Proposed Public Offering
19 1 2021 16:05:50 提供 Nasdaq GlobeNewswire
-
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
19 1 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
11 1 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
04 1 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
04 1 2021 07:00:00 提供 Nasdaq GlobeNewswire